USPTO serial 90251008
COVACOAT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 17, 2026
- Examiner
- GAGLIARDI, JEANINE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with COVACOAT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Mississauga, Ontario, CA
Mississauga, Ontario, CA
Mississauga, Ontario, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Seth A. Rose
Seth A. Rose LOEB & LOEB LLP321 NORTH CLARK STREET, SUITE 2300CHICAGO, IL 60654United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical, surgical, dental and veterinary apparatus, instruments and devices featuring chemical surface coatings, namely anatomical bandages for joints, compression bandages, elastic bandages for dressings, hernia bandages, support bandages, non-invasive medical ECG and EEG electrodes and leads, medical implantable electrodes in the nature of cortical, defibrillator, pacemaker, and stimulator electrodes, reusable surgical instruments, single-use scalpels, forceps for medical use, biopsy needles, syringe needles for medical use, needles used for suturing, absorbable and non-absorbable sutures, cannulas in the nature of infusion, brain, coronary, and ventricular cannulas, intra-ocular lenses, surgical devices in the nature of annuloplasty rings, enteral feeding pump tubes, medical tracheal tubes, medical tubing for use with infusion pumps, medical nasal gastric tubes, medical liquid and gas-flow tubes for epidural and spinal catheters, contraceptive apparatus in the nature of contraceptive implants, contraceptive coils, contraceptive diaphragms, intrauterine devices for contraception, contraceptive clips, contraceptive bands, contraceptive inserts for use with fallopian tubes, and contraceptive clips and bands for use with vas deferens, artificial embolization prevention implants, cardiovascular patches in the nature of heart monitors, intracardiac patch prostheses, mammary prostheses, vascular prostheses, infusion ports being implantable ports, infusion port catheters, suction catheters, angiography catheters, cardiac catheters, cerebrospinal catheters, hydrocephalic catheters, intravascular catheters, ventricular neurological catheters, vascular perfusion catheters, cardiovascular stents, iliac stents, surgical biliary, intermittent, abscess, and thoracic drains, surgical cerebrospinal drains, carotid artery shunts being medical tubing, sutures, catheters, and urethral catheters, medical tubing in the nature of IV lines and haemodialysis lines, masks for use by medical personnel, gloves for use by medical personnel being medical gloves, medical gowns, surgical gowns, patient examination gowns, hospital bedding being draw-sheets for sick beds, hospital scrubs being surgical scrub suits, therapeutic compression bed sheets; diagnostic test devices featuring chemical surface coatings, namely, urine drug test kits comprised of medical diagnostic instruments for the analysis of body fluids, urine pregnancy test kits comprised of medical diagnostic instruments for the analysis of body fluids, saliva drug test kits comprised diagnostic instruments for the analysis of body fluids, saliva alcohol test kits comprised of diagnostic instruments for the analysis of body fluids, blood collection tubes being blood testing apparatus in the nature of blood sampling tubes, cholesterol and blood glucose test kits comprised of cholesterol meters and blood glucose meters, in vitro diagnostic accessories in the nature of medical diagnostic apparatus for testing for viruses; orthopaedic articles featuring chemical surface coatings, namely, artificial hip implants, artificial knee implants, artificial shoulder implants, artificial maxilla-facial implants, implantable surgical staples, prosthetic joint replacements in the nature of artificial materials for use in the replacement of bones, cortical screws being metal screws for medical use, cancellous screws being metal screws for medical use, interference screws being metal screws for medical use, soft tissue suture anchors, dynamic compression screws being metal screws for medical use, intramedullary fixation devices in the nature of orthopedic fixation device used in orthopedic transplant and/or implant surgery, buttress plates being surgical implants in the nature of metal plates, neutralization plates being surgical implants in the nature of metal plates, bridging plates being surgical implants in the nature of metal plates, tension plates being surgical implants in the nature of metal plates, compression plates being surgical implants in the nature of metal plates, orthopaedic implants made of artificial materials; suture materials featuring chemical surface coatings, therapeutic and assistive devices adapted for persons with disabilities, namely, diathermy units in the nature of electric heating devices for curative treatment, electrical stimulation and electrotherapy equipment in the nature of electrotherapy devices for providing transcutaneous electrical nerve stimulation, infrared heat, and compression, light therapy equipment in the nature of sensory light therapy unit and laser therapy devices being laser therapy apparatus for pain relief, magnet therapy devices in the nature of apparatus for magnet therapy, neuromuscular stimulators being nerve stimulator apparatus, therapeutic ultrasound machines being ultrasound appliances for medical use, walkers to aid in mobility, walking canes for medical purposes, crutches, prosthetic devices being artificial materials for use in the replacement of bones, and orthotic devices being orthotics for the foot and hand | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 17, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 17, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 27, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 27, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 21, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 5, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 5, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 5, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 5, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 5, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 10, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 10, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 10, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Sep 11, 2025 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Sep 11, 2025 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Sep 11, 2025 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Sep 1, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Feb 28, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 28, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 28, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 26, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 26, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 26, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Dec 5, 2024 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Dec 5, 2024 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Dec 5, 2024 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Dec 4, 2024 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 19, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Dec 19, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Dec 19, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Dec 11, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 11, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 11, 2023 | ALIE | ASSIGNED TO LIE | — |
| Jul 12, 2023 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Apr 24, 2023 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Apr 24, 2023 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Apr 24, 2023 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Apr 20, 2023 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 17, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 17, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 17, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 3, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 3, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 3, 2022 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| May 24, 2022 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| May 24, 2022 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| May 24, 2022 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| May 4, 2022 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Sep 9, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 9, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 9, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Aug 18, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 18, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 18, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 18, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 12, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 30, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 16, 2020 | NWAP | NEW APPLICATION ENTERED | — |